Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
- PMID: 10029592
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
Abstract
Dendritic cells (DC) are critically involved in the initiation of primary immune processes, including tumor rejection. In our study, we investigated the effect of interleukin-10 (IL-10)-treated human DC on the properties of CD8(+) T cells that are known to be essential for the destruction of tumor cells. We show that IL-10-pretreatment of DC not only reduces their allostimulatory capacity, but also induces a state of alloantigen-specific anergy in both primed and naive (CD45RA+) CD8(+) T cells. To investigate the influence of IL-10-treated DC on melanoma-associated antigen-specific T cells, we generated a tyrosinase-specific CD8(+) T-cell line by several rounds of stimulation with the specific antigen. After coculture with IL-10-treated DC, restimulation of the T-cell line with untreated, antigen-pulsed DC demonstrated peptide-specific anergy in the tyrosinase-specific T cells. Addition of IL-2 to the anergic T cells reversed the state of both alloantigen- or peptide-specific anergy. In contrast to optimally stimulated CD8(+) T cells, anergic tyrosinase-specific CD8(+) T cells, after coculture with peptide-pulsed IL-10-treated DC, failed to lyse an HLA-A2-positive and tyrosinase-expressing melanoma cell line. Thus, our data demonstrate that IL-10-treated DC induce an antigen-specific anergy in cytotoxic CD8(+) T cells, a process that might be a mechanism of tumors to inhibit immune surveillance by converting DC into tolerogenic antigen-presenting cells.
Similar articles
-
CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.Blood. 2002 Apr 1;99(7):2468-76. doi: 10.1182/blood.v99.7.2468. Blood. 2002. PMID: 11895781
-
IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.Eur J Immunol. 2007 Jun;37(6):1678-90. doi: 10.1002/eji.200636329. Eur J Immunol. 2007. PMID: 17492620
-
Induction of tolerance by IL-10-treated dendritic cells.J Immunol. 1997 Nov 15;159(10):4772-80. J Immunol. 1997. PMID: 9366401
-
Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.J Immunol. 2003 Sep 1;171(5):2251-61. doi: 10.4049/jimmunol.171.5.2251. J Immunol. 2003. PMID: 12928369
-
Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience.Semin Immunol. 2019 Aug;44:101325. doi: 10.1016/j.smim.2019.101325. Epub 2019 Nov 6. Semin Immunol. 2019. PMID: 31706853 Free PMC article. Review.
Cited by
-
Trypanosoma cruzi as an effective cancer antigen delivery vector.Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19695-700. doi: 10.1073/pnas.1110030108. Epub 2011 Nov 23. Proc Natl Acad Sci U S A. 2011. PMID: 22114198 Free PMC article.
-
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.J Exp Clin Cancer Res. 2012 May 16;31(1):47. doi: 10.1186/1756-9966-31-47. J Exp Clin Cancer Res. 2012. PMID: 22592077 Free PMC article.
-
Tolerogenic dendritic cells.Semin Immunopathol. 2017 Feb;39(2):113-120. doi: 10.1007/s00281-016-0587-8. Epub 2016 Sep 19. Semin Immunopathol. 2017. PMID: 27646959 Free PMC article. Review.
-
Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.Exp Ther Med. 2016 May;11(5):1625-1632. doi: 10.3892/etm.2016.3169. Epub 2016 Mar 15. Exp Ther Med. 2016. PMID: 27168782 Free PMC article.
-
Overcoming tumor immune evasion with an unique arbovirus.J Transl Med. 2015 Jan 16;13:3. doi: 10.1186/s12967-014-0349-0. J Transl Med. 2015. PMID: 25592450 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials